Liquid Biopsy Biomarkers for Immunotherapy in Non-Small Cell Lung Carcinoma: Lessons Learned and the Road Ahead

Over the recent years, advances in the development of anti-cancer treatments, particularly the implementation of ICIs (immune checkpoint inhibitors), have resulted in increased survival rates in NSCLC (non-small cell lung cancer) patients. However, a significant proportion of patients does not seem...

Descripción completa

Detalles Bibliográficos
Autores principales: Hita-Millan, Jesus, Carracedo, Angel, Fernandez-Rozadilla, Ceres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540302/
https://www.ncbi.nlm.nih.gov/pubmed/34683113
http://dx.doi.org/10.3390/jpm11100971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540302/
https://www.ncbi.nlm.nih.gov/pubmed/34683113
http://dx.doi.org/10.3390/jpm11100971

Ejemplares similares